Menu

Impact Events

More
Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
11/22/17 ProMetic (PLI:CN) IVIG for Primary Immunodeficiencies Subscribers Only Subscribers Only Subscribers Only
11/22/17 Puma Biotechnology (PBYI) Nerlynx for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
11/22/17 Khondrion KH176 for Mitochondrial Respiratory-Chain Diseases Subscribers Only Subscribers Only Subscribers Only
11/21/17 GlaxoSmithKline (GSK) Juluca for HIV / AIDS Subscribers Only Subscribers Only Subscribers Only
11/21/17 Cytokinetics (CYTK) Tirasemtiv for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected
Date Range
Lead
Company
Drug Expected
Catalyst
11/24/17 Subscribers Only Subscribers Only Trial Data - Updated Results
11/24/17 Subscribers Only Subscribers Only Trial Data - Updated Results
11/25/17 Subscribers Only Subscribers Only Patent - Expiration
11/27/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
11/27/17 Subscribers Only Subscribers Only Progress Update - Product Launch (Japan)
Back to the top Back to the top